Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Renoprotective Effects of Fluid Prophylaxis Strategies for Contrast Induced Nephropathy (CIN) (CIN)

This study has been withdrawn prior to enrollment.
(No funding received)
Sponsor:
Collaborator:
University of Alberta
Information provided by (Responsible Party):
Brendan Barrett, Memorial University of Newfoundland
ClinicalTrials.gov Identifier:
NCT00749827
First received: September 5, 2008
Last updated: April 19, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given